103 related articles for article (PubMed ID: 2470892)
1. Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro.
Baba M; Schols D; Nakashima H; Pauwels R; Parmentier G; Meijer DK; De Clercq E
J Acquir Immune Defic Syndr (1988); 1989; 2(3):264-71. PubMed ID: 2470892
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906
[TBL] [Abstract][Full Text] [Related]
3. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
[TBL] [Abstract][Full Text] [Related]
4. Amino functionalized novel cholic acid derivatives induce HIV-1 replication and syncytia formation in T cells.
Salunke DB; Ravi DS; Pore VS; Mitra D; Hazra BG
J Med Chem; 2006 Apr; 49(8):2652-5. PubMed ID: 16610808
[TBL] [Abstract][Full Text] [Related]
5. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
6. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.
Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S
Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749
[TBL] [Abstract][Full Text] [Related]
7. Cholic acid derivatives against HIV replication.
Lloyd G; Atkinson T; Sutton PM
J Acquir Immune Defic Syndr (1988); 1990; 3(3):290. PubMed ID: 2304004
[No Abstract] [Full Text] [Related]
8. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of sulfate esters of lithocholic acid, glycolithocholic acid, and taurolithocholic acid with sulfur trioxide-triethylamine.
Tserng KY; Klein PD
J Lipid Res; 1977 Jul; 18(4):491-5. PubMed ID: 894140
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of human immunodeficiency virus type 1 replication by novel fluoroalkylated oligomers in vitro.
Baba M; Kira T; Shigeta S; Matsumoto T; Sawada H
J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):24-30. PubMed ID: 8263750
[TBL] [Abstract][Full Text] [Related]
11. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro.
Ito M; Baba M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; De Clercq E
Biochem Biophys Res Commun; 1989 Jan; 158(1):307-12. PubMed ID: 2912452
[TBL] [Abstract][Full Text] [Related]
13. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells.
Nonaka G; Nishioka I; Nishizawa M; Yamagishi T; Kashiwada Y; Dutschman GE; Bodner AJ; Kilkuskie RE; Cheng YC; Lee KH
J Nat Prod; 1990; 53(3):587-95. PubMed ID: 1698933
[TBL] [Abstract][Full Text] [Related]
14. Maleylated human serum albumin inhibits HIV-1 infection in vitro.
Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H
Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431
[TBL] [Abstract][Full Text] [Related]
15. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
16. 2,3,7,8-Tetrachlorodibenzo-P-dioxin as a possible activator of HIV infection.
Pokrovsky AG; Cherykh AI; Yastrebova ON; Tsyrlov IB
Biochem Biophys Res Commun; 1991 Aug; 179(1):46-51. PubMed ID: 1715696
[TBL] [Abstract][Full Text] [Related]
17. Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes.
Ding L; Balzarini J; Schols D; Meunier B; de Clercq E
Biochem Pharmacol; 1992 Oct; 44(8):1675-9. PubMed ID: 1384504
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
[TBL] [Abstract][Full Text] [Related]
19. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro.
Balzarini J; Neyts J; Schols D; Hosoya M; Van Damme E; Peumans W; De Clercq E
Antiviral Res; 1992 Jun; 18(2):191-207. PubMed ID: 1329650
[TBL] [Abstract][Full Text] [Related]
20. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
